Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 369

1.

Study Design and Rationale for the Mood and Methylation Study: A Platform for Multi-Omics Investigation of Depression in Twins.

Strachan E, Zhao J, Roy-Byrne PP, Fowler E, Bacus T.

Twin Res Hum Genet. 2018 Dec;21(6):507-513. doi: 10.1017/thg.2018.64. Epub 2018 Nov 28.

PMID:
30484417
2.

High expectancy and early response produce optimal effects in sertraline treatment for post-traumatic stress disorder.

Graham B, Garcia NM, Burton MS, Cooper AA, Roy-Byrne PP, Mavissakalian MR, Feeny NC, Zoellner LA.

Br J Psychiatry. 2018 Dec;213(6):704-708. doi: 10.1192/bjp.2018.211. Epub 2018 Oct 25.

PMID:
30355364
3.

Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD.

Zoellner LA, Roy-Byrne PP, Mavissakalian M, Feeny NC.

Am J Psychiatry. 2019 Apr 1;176(4):287-296. doi: 10.1176/appi.ajp.2018.17090995. Epub 2018 Oct 19.

PMID:
30336702
4.

Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance users.

Wolitzky-Taylor K, Drazdowski TK, Niles A, Roy-Byrne P, Ries R, Rawson R, Craske MG.

Behav Res Ther. 2018 Aug;107:34-41. doi: 10.1016/j.brat.2018.05.010. Epub 2018 May 24.

PMID:
29852309
5.

Who needs more than standard care? Treatment moderators in a randomized clinical trial comparing addiction treatment alone to addiction treatment plus anxiety disorder treatment for comorbid anxiety and substance use disorders.

Wolitzky-Taylor K, Niles AN, Ries R, Krull JL, Rawson R, Roy-Byrne P, Craske M.

Behav Res Ther. 2018 Aug;107:1-9. doi: 10.1016/j.brat.2018.05.005. Epub 2018 May 17.

PMID:
29800622
6.

Childhood Trauma, DNA Methylation of Stress-Related Genes, and Depression: Findings From Two Monozygotic Twin Studies.

Peng H, Zhu Y, Strachan E, Fowler E, Bacus T, Roy-Byrne P, Goldberg J, Vaccarino V, Zhao J.

Psychosom Med. 2018 Sep;80(7):599-608. doi: 10.1097/PSY.0000000000000604.

PMID:
29781947
7.

Cultural influences on mental health symptoms in a primary care sample of Latinx patients.

Escovar EL, Craske M, Roy-Byrne P, Stein MB, Sullivan G, Sherbourne CD, Bystritsky A, Chavira DA.

J Anxiety Disord. 2018 Apr;55:39-47. doi: 10.1016/j.janxdis.2018.03.005. Epub 2018 Mar 12.

8.

Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics.

Wolitzky-Taylor K, Krull J, Rawson R, Roy-Byrne P, Ries R, Craske MG.

J Consult Clin Psychol. 2018 Jan;86(1):81-88. doi: 10.1037/ccp0000276.

9.

Age Differences in Death and Suicidal Ideation in Anxious Primary Care Patients.

Petkus AJ, Wetherell JL, Stein MB, Chavira DA, Craske MG, Sherbourne C, Sullivan G, Bystritsky A, Roy-Byrne P.

Clin Gerontol. 2018 Jul-Sep;41(4):271-281. doi: 10.1080/07317115.2017.1356893. Epub 2017 Sep 29.

PMID:
28960158
10.

Transdiagnostic Cognitive Behavioral Therapy and the Return of the Repressed.

Roy-Byrne P.

JAMA Psychiatry. 2017 Sep 1;74(9):867-868. doi: 10.1001/jamapsychiatry.2017.1982. No abstract available.

PMID:
28768336
11.

Changing of the guard at Depression and Anxiety.

Roy-Byrne PP, Stein MB.

Depress Anxiety. 2017 Jul;34(7):575. doi: 10.1002/da.22663. No abstract available.

PMID:
28686359
12.

Advancing Personalized Medicine: Application of a Novel Statistical Method to Identify Treatment Moderators in the Coordinated Anxiety Learning and Management Study.

Niles AN, Loerinc AG, Krull JL, Roy-Byrne P, Sullivan G, Sherbourne CD, Bystritsky A, Craske MG.

Behav Ther. 2017 Jul;48(4):490-500. doi: 10.1016/j.beth.2017.02.001. Epub 2017 Feb 23.

13.

Changes in Physical Activity Barriers among American Indian Elders: A Pilot Study‚Äč.

Sawchuk CN, Russo JE, Roy-Byrne P, Goldberg J, Forquera R, Buchwald D.

Am Indian Alsk Native Ment Health Res. 2017;24(1):127-140. doi: 10.5820/aian.2401.2017.127.

PMID:
28562839
14.

Response to Urine Drug Testing in a Family Residency Practice.

McDonell MG, West II, Ries RK, Donovan DM, Bumgardner K, Dunn C, Atkins DC, Roy-Byrne P, Maynard C.

J Addict Med. 2017 May/Jun;11(3):243. doi: 10.1097/ADM.0000000000000283. No abstract available. Erratum in: J Addict Med. 2018 Nov/Dec;12(6):501.

15.

Do changes in trauma-related beliefs predict PTSD symptom improvement in prolonged exposure and sertraline?

Cooper AA, Zoellner LA, Roy-Byrne P, Mavissakalian MR, Feeny NC.

J Consult Clin Psychol. 2017 Sep;85(9):873-882. doi: 10.1037/ccp0000220. Epub 2017 May 15.

16.

Prediction of Suicide Ideation and Attempt Among Substance-Using Patients in Primary Care.

Hallgren KA, Ries RK, Atkins DC, Bumgardner K, Roy-Byrne P.

J Am Board Fam Med. 2017 Mar-Apr;30(2):150-160. doi: 10.3122/jabfm.2017.02.160264.

17.

Collaborative Care for Anxiety: What's Inside the Black Box and How Can It Be Improved?

Roy-Byrne P.

J Gen Intern Med. 2017 Mar;32(3):233-235. doi: 10.1007/s11606-016-3921-x. No abstract available.

18.

Improving outcomes for patients with medication-resistant anxiety: effects of collaborative care with cognitive behavioral therapy.

Campbell-Sills L, Roy-Byrne PP, Craske MG, Bystritsky A, Sullivan G, Stein MB.

Depress Anxiety. 2016 Dec;33(12):1099-1106. doi: 10.1002/da.22574. Epub 2016 Oct 24.

PMID:
27775823
19.

Panic attacks and panic disorder in the American Indian community.

Sawchuk CN, Roy-Byrne P, Noonan C, Craner JR, Goldberg J, Manson S, Buchwald D; AI-SUPERPFP Team.

J Anxiety Disord. 2017 May;48:6-12. doi: 10.1016/j.janxdis.2016.10.004. Epub 2016 Oct 5.

20.

Utility of Point-of-care Urine Drug Tests in the Treatment of Primary Care Patients With Drug Use Disorders.

McDonell MG, Graves MC, West II, Ries RK, Donovan DM, Bumgardner K, Krupski A, Dunn C, Maynard C, Atkins DC, Roy-Byrne P.

J Addict Med. 2016 May-Jun;10(3):196-201. doi: 10.1097/ADM.0000000000000220.

21.

Within-Provider Variability in Motivational Interviewing Integrity for Three Years after MI Training: Does Time Heal?

Dunn C, Darnell D, Atkins DC, Hallgren KA, Imel ZE, Bumgardner K, Owens M, Roy-Byrne P.

J Subst Abuse Treat. 2016 Jun;65:74-82. doi: 10.1016/j.jsat.2016.02.008. Epub 2016 Mar 4.

PMID:
27016875
22.

Barriers and Facilitators to Coordinating Care With High-Risk, High-Cost Disabled Medicaid Beneficiaries: Perspectives of Frontline Staff and Participating Clients.

Cristofalo M, Krupski A, West II, Atkins DC, Joesch JM, Jenkins L, Court B, Bell J, Roy-Byrne P.

Care Manag J. 2016;17(1):24-36. doi: 10.1891/1521-0987.17.1.24.

PMID:
26984691
23.

Suicide risk and associated demographic and clinical correlates among primary care patients with recent drug use.

Carmel A, Ries R, West II, Bumgardner K, Roy-Byrne P.

Am J Drug Alcohol Abuse. 2016 May;42(3):351-7. doi: 10.3109/00952990.2015.1133634. Epub 2016 Feb 24.

24.

TRANSLATING RESEARCH TO PRACTICE: TOO MUCH RESEARCH, NOT ENOUGH PRACTICE?

Roy-Byrne P.

Depress Anxiety. 2015 Nov;32(11):785-6. doi: 10.1002/da.22443. Epub 2015 Oct 26. No abstract available.

PMID:
26501391
25.

IN MEMORIAM: REMEMBERING ALIES MUSKIN.

Roy-Byrne P.

Depress Anxiety. 2015 Nov;32(11):783-4. doi: 10.1002/da.22448. Epub 2015 Oct 21. No abstract available.

PMID:
26488544
26.

Latent dimensions of social anxiety disorder: A re-evaluation of the Social Phobia Inventory (SPIN).

Campbell-Sills L, Espejo E, Ayers CR, Roy-Byrne P, Stein MB.

J Anxiety Disord. 2015 Dec;36:84-91. doi: 10.1016/j.janxdis.2015.09.007. Epub 2015 Sep 18.

27.

Correlates of Opioid Use in Adults With Self-Reported Drug Use Recruited From Public Safety-Net Primary Care Clinics.

Ries R, Krupski A, West II, Maynard C, Bumgardner K, Donovan D, Dunn C, Roy-Byrne P.

J Addict Med. 2015 Sep-Oct;9(5):417-26. doi: 10.1097/ADM.0000000000000151.

28.

Clinical Needs of Patients with Problem Drug Use.

Krupski A, West II, Graves MC, Atkins DC, Maynard C, Bumgardner K, Donovan D, Ries R, Roy-Byrne P.

J Am Board Fam Med. 2015 Sep-Oct;28(5):605-16. doi: 10.3122/jabfm.2015.05.150004.

29.

Are medical marijuana users different from recreational users? The view from primary care.

Roy-Byrne P, Maynard C, Bumgardner K, Krupski A, Dunn C, West II, Donovan D, Atkins DC, Ries R.

Am J Addict. 2015 Oct;24(7):599-606. doi: 10.1111/ajad.12270. Epub 2015 Sep 4.

PMID:
26337603
30.

Chronic Disease and Chemical Dependency Treatment in Primary Care Patients With Problem Drug Use.

Maynard C, Graves M, West II, Bumgardner K, Krupski A, Roy-Byrne P.

J Addict Dis. 2015;34(4):323-9. doi: 10.1080/10550887.2015.1078133.

PMID:
26280390
31.

Treatment-refractory anxiety; definition, risk factors, and treatment challenges.

Roy-Byrne P.

Dialogues Clin Neurosci. 2015 Jun;17(2):191-206. Review.

32.

Course of symptom change during anxiety treatment: Reductions in anxiety and depression in patients completing the Coordinated Anxiety Learning and Management program.

Bomyea J, Lang A, Craske MG, Chavira DA, Sherbourne CD, Rose RD, Golinelli D, Campbell-Sills L, Welch SS, Sullivan G, Bystritsky A, Roy-Byrne P, Stein MB.

Psychiatry Res. 2015 Sep 30;229(1-2):133-42. doi: 10.1016/j.psychres.2015.07.056. Epub 2015 Jul 21.

33.

Comparison of Homeless and Non-Homeless Problem Drug Users Recruited from Primary Care Safety-Net Clinics.

Krupski A, Graves MC, Bumgardner K, Roy-Byrne P.

J Subst Abuse Treat. 2015 Nov;58:84-9. doi: 10.1016/j.jsat.2015.06.007. Epub 2015 Jun 17.

34.

Improving Relationships in Trauma Victims: The Case for Interpersonal Psychotherapy and PTSD.

Roy-Byrne P.

Am J Psychiatry. 2015 May;172(5):403-5. doi: 10.1176/appi.ajp.2015.15010099. No abstract available.

PMID:
25930126
35.

The Association of Panic Disorder, Posttraumatic Stress Disorder, and Major Depression With Smoking in American Indians.

Sawchuk CN, Roy-Byrne P, Noonan C, Bogart A, Goldberg J, Manson SM, Buchwald D; AI-SUPERPFP Team.

Nicotine Tob Res. 2016 Mar;18(3):259-66. doi: 10.1093/ntr/ntv071. Epub 2015 Apr 6.

36.

The role of gender in moderating treatment outcome in collaborative care for anxiety.

Grubbs KM, Cheney AM, Fortney JC, Edlund C, Han X, Dubbert P, Sherbourne CD, Craske MG, Stein MB, Roy-Byrne PP, Sullivan JG.

Psychiatr Serv. 2015 Mar 1;66(3):265-71. doi: 10.1176/appi.ps.201400049. Epub 2014 Dec 15.

37.

The impact of alcohol use severity on anxiety treatment outcomes in a large effectiveness trial in primary care.

Wolitzky-Taylor K, Brown LA, Roy-Byrne P, Sherbourne C, Stein MB, Sullivan G, Bystritsky A, Craske MG.

J Anxiety Disord. 2015 Mar;30:88-93. doi: 10.1016/j.janxdis.2014.12.011. Epub 2015 Jan 8.

38.

Comparing the motivational interviewing integrity in two prevalent models of brief intervention service delivery for primary care settings.

Dunn C, Darnell D, Carmel A, Atkins DC, Bumgardner K, Roy-Byrne P.

J Subst Abuse Treat. 2015 Apr;51:47-52. doi: 10.1016/j.jsat.2014.10.009. Epub 2014 Nov 5.

39.

Anxiety and depressive symptoms and medical illness among adults with anxiety disorders.

Niles AN, Dour HJ, Stanton AL, Roy-Byrne PP, Stein MB, Sullivan G, Sherbourne CD, Rose RD, Craske MG.

J Psychosom Res. 2015 Feb;78(2):109-15. doi: 10.1016/j.jpsychores.2014.11.018. Epub 2014 Nov 25.

40.

Self-reported Usual Care for Self-directed Violence During the 6 Months Before Emergency Department Admission.

Comtois KA, Kerbrat AH, Atkins DC, Roy-Byrne P, Katon W.

Med Care. 2015 Jan;53(1):45-53. doi: 10.1097/MLR.0000000000000252.

41.

A randomized controlled trial of intensive care management for disabled Medicaid beneficiaries with high health care costs.

Bell JF, Krupski A, Joesch JM, West II, Atkins DC, Court B, Mancuso D, Roy-Byrne P.

Health Serv Res. 2015 Jun;50(3):663-89. doi: 10.1111/1475-6773.12258. Epub 2014 Nov 26.

42.

An examination of the bidirectional relationship between functioning and symptom levels in patients with anxiety disorders in the CALM study.

Brown LA, Krull JL, Roy-Byrne P, Sherbourne CD, Stein MB, Sullivan G, Rose RD, Bystritsky A, Craske MG.

Psychol Med. 2015 Feb;45(3):647-61. doi: 10.1017/S0033291714002062. Epub 2014 Oct 2.

43.

Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial.

Roy-Byrne P, Bumgardner K, Krupski A, Dunn C, Ries R, Donovan D, West II, Maynard C, Atkins DC, Graves MC, Joesch JM, Zarkin GA.

JAMA. 2014 Aug 6;312(5):492-501. doi: 10.1001/jama.2014.7860.

44.

Transcranial magnetic stimulation in the treatment of chronic widespread pain: a randomized controlled study.

Avery DH, Zarkowski P, Krashin D, Rho WK, Wajdik C, Joesch JM, Haynor DR, Buchwald D, Roy-Byrne P.

J ECT. 2015 Mar;31(1):57-66. doi: 10.1097/YCT.0000000000000125.

45.

Treatment engagement and response to CBT among Latinos with anxiety disorders in primary care.

Chavira DA, Golinelli D, Sherbourne C, Stein MB, Sullivan G, Bystritsky A, Rose RD, Lang AJ, Campbell-Sills L, Welch S, Bumgardner K, Glenn D, Barrios V, Roy-Byrne P, Craske M.

J Consult Clin Psychol. 2014 Jun;82(3):392-403. doi: 10.1037/a0036365. Epub 2014 Mar 24.

46.

No change in neuropsychological functioning after receiving repetitive transcranial magnetic stimulation treatment for major depression.

Wajdik C, Claypoole KH, Fawaz W, Holtzheimer PE 3rd, Neumaier J, Dunner DL, Haynor DR, Roy-Byrne P, Avery DH.

J ECT. 2014 Dec;30(4):320-4. doi: 10.1097/YCT.0000000000000096.

47.

Changes in self-efficacy and outcome expectancy as predictors of anxiety outcomes from the CALM study.

Brown LA, Wiley JF, Wolitzky-Taylor K, Roy-Byrne P, Sherbourne C, Stein MB, Sullivan G, Rose RD, Bystritsky A, Craske MG.

Depress Anxiety. 2014 Aug;31(8):678-89. doi: 10.1002/da.22256. Epub 2014 Mar 11.

48.

Treatment in nonresponsive patients with social anxiety: back to the future with benzodiazepines.

Roy-Byrne P.

Am J Psychiatry. 2014 Jan;171(1):1-4. doi: 10.1176/appi.ajp.2013.13101304. No abstract available.

PMID:
24399419
49.

Perceived social support mediates anxiety and depressive symptom changes following primary care intervention.

Dour HJ, Wiley JF, Roy-Byrne P, Stein MB, Sullivan G, Sherbourne CD, Bystritsky A, Rose RD, Craske MG.

Depress Anxiety. 2014 May;31(5):436-42. doi: 10.1002/da.22216. Epub 2013 Dec 12.

50.

Suicide: the long and winding road from research to practice.

Roy-Byrne P.

Depress Anxiety. 2013 Oct;30(10):893-5. doi: 10.1002/da.22181. No abstract available.

PMID:
24108487

Supplemental Content

Loading ...
Support Center